Effects of Illicit Drug Use on Adherence to Prescribed Antiretroviral Medication

American Journal on Addictions

Volumn 12, Issue 5, 2003, Pages 455-458

  Rosen, Marc I ^a   Rigsby, Michael O ^a   Dieckhaus, Kevin D ^b   Cramer, Joyce A ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ABSTINENCE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PREFERENCE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; MALE; PATIENT COMPLIANCE; PRESCRIPTION; SUBSTANCE ABUSE;

EID: 0344494701     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2003.tb00488.x     Document Type: Article

References (10)

1. Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomized placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet. 1998;351:543-549.
2. Vanhove GF, Schapiro JM, Winters MA, Merigan TC, Blaschke TF. Patient compliance and drug failure in protease inhibitor monotherapy [letter]. JAMA. 1996;276:1955-1956.
3. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
4. Wenger N, Gifford A, Liu H, et al. Patient characteristics and attitudes associated with antiretroviral (AR) adherence. Poster presented at 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois; January 31-February 4, 1999.
5. Hecht FM, Colfax G, Swanson M, Chesney M. Adherence and effectiveness of protease inhibitors in clinical practice. 5th Conference on Retroviruses and Opportunistic Infections. Abstract 151. Chicago, Illinois; February 2-6 1998.
6. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs. 1999;13:185-197.
7. Williams A, Friedland G. Adherence, compliance, and HAART. AIDS Clinical Care. 1997;9:51-54,58.
8. Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystics prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18:117-125.
9. Sobell LC, Sobell MB, Leo GI, Cancilla A. Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict. 1988;83:393-402.
10. Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Inter Med. 2000;15:841-847.